VERONA PHARMA PLC.

VRNA US9250501064

🆔
Registration No.
05375156
💰
Capitalization
Mid-cap

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.

Annual Performance 1
2021 2022 2023 2024 2025
-5% 275% -19% 147% 0%
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
96
🙍
Insiders
13
Person Price Shares Total Published Completed
Deschamps Lisa
O
13.14
USD
9,464
Sold
124,392
USD
01/08/2025 01/08/2025
Hahn Mark W
CFO
13.14
USD
208,912
Sold
2,745,877
USD
01/08/2025 01/08/2025
Edwards Martin
O
13.14
USD
10,808
Sold
142,057
USD
01/08/2025 01/08/2025
Ackermann Christina
O
13.14
USD
1,808
Sold
23,764
USD
01/08/2025 01/08/2025
Ebsworth David R
O
13.14
USD
1,904
Sold
25,026
USD
01/08/2025 01/08/2025
Brady James Aloysius
O
13.14
USD
824
Sold
10,830
USD
01/08/2025 01/08/2025
Cunningham Kenneth
O
13.14
USD
10,808
Sold
142,057
USD
01/08/2025 01/08/2025
Fisher Andrew
SR OFF
13.14
USD
9,584
Sold
125,969
USD
01/08/2025 01/08/2025
Zaccardelli David
CEO
13.14
USD
208,912
Sold
2,745,877
USD
01/08/2025 01/08/2025
Sinha Vikas
O
13.14
USD
4,328
Sold
56,886
USD
01/08/2025 01/08/2025

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include VERONA PHARMA PLC. to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Historical Performance
1M 3M 6M 1Y 3Y 5Y All Time
38% 119% 203% 134% 575% 298% 257%
Last 52W Low 52W High All-Time Low All-Time High β
106.91 32.68 106.91 2.16 106.91
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Hahn Mark W 36 42,814,698.89 1,189,297.19 12/08/2024 01/08/2025
Zaccardelli David 28 28,399,074.17 1,014,252.65 12/08/2024 01/08/2025
Rickard Kathleen A. 8 3,662,142.17 457,767.77 03/11/2023 01/08/2025
Sinha Vikas 4 2,987,141.93 746,785.48 29/04/2025 01/08/2025
Fisher Andrew 5 2,653,295.78 530,659.16 29/04/2025 01/08/2025
Ebsworth David R 5 722,106.37 144,421.27 06/11/2023 01/08/2025
Ackermann Christina 3 559,749.37 186,583.12 06/11/2024 01/08/2025
Edwards Martin 2 204,030.14 102,015.07 20/11/2023 01/08/2025
Austwick Michael 1 148,366.09 148,366.09 01/08/2025 01/08/2025
Cunningham Kenneth 1 142,057.11 142,057.11 01/08/2025 01/08/2025
Deschamps Lisa 1 124,391.98 124,391.98 01/08/2025 01/08/2025
Shah Mahendra 1 47,422.47 47,422.47 01/08/2025 01/08/2025
Brady James Aloysius 1 10,830.41 10,830.41 01/08/2025 01/08/2025

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.